Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

3.8%

2 terminated/withdrawn out of 52 trials

Late-Stage Pipeline

42%

22 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

31 recruiting

Enrollment reporting

Analytics

Phase 3

18(34.6%)

Phase 2

15(28.8%)

Phase 1

7(13.5%)

Phase 4

4(7.7%)

Phase 1/2

4(7.7%)

Phase 2/3

2(3.8%)

N/A

2(3.8%)

52Total

Phase 3(18)

Phase 2(15)

Phase 1(7)

Phase 4(4)

+3 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (52)

Showing 20 of 52 trials

NCT07278661Phase 2Recruiting

Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery.

Role: lead

NCT07345325Phase 3Recruiting

Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve Endocarditis

Role: lead

NCT07391332Phase 2Recruiting

Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER : a Pilot Study

Role: lead

NCT07503834Phase 1/2Recruiting

"IL-1β Blockade to Prevent Immunothrombosis in Recipients of a Pancreatic Organ"

Role: lead

NCT06023706Phase 3Recruiting

Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.

Role: lead

NCT07869173Phase 3Not Yet Recruiting

"Evaluation of the Efficacy of Intravenous Lidocaine on Chronic Post-operative Pain in Patients Requiring Emergency Abdominal Surgery. A Multicentre, Randomised, Controlled, Double-blind Study."

Role: lead

NCT04561492Phase 2Active Not Recruiting

Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma

Role: lead

NCT05642208Phase 4Completed

Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis

Role: lead

NCT02558816Phase 1/2Completed

A Trial of Obinutuzumab,GDC-0199 Plus Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma Patients

Role: lead

NCT07549841Phase 2Recruiting

Exploratory Study Evaluating the Relevance of [68Ga]Ga-FAPI-46 for Staging and Identifying Progressing Patients With Transthyretin Cardiac Amyloidosis

Role: lead

NCT07274254Phase 3Recruiting

Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease

Role: lead

NCT06999837Not ApplicableRecruiting

[68Ga]Ga-PSMA PET/CT in Hepatocellular Carcinoma: Impact of Multiparametric Dynamic Whole-body Imaging and Kinetic Modeling.

Role: lead

NCT06269900Phase 3Recruiting

Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype

Role: lead

NCT06356922Phase 1/2Active Not Recruiting

Study Assessing RLT Using [177Lu]Lu-PentixaTher for Relapsed/Refractory CXCR4+ Acute Leukemia.

Role: lead

NCT07319208Phase 3Recruiting

Efficacy of Early Continuous Infusion of HSS on the Neurological Outcome at 6 Months in TBI Patients.

Role: lead

NCT06995287Phase 3Recruiting

Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Pelvic Pain Suggestive of Dysmenorrhea

Role: lead

NCT07680504Phase 2Not Yet Recruiting

A Pilot Superiority Study Comparing the Efficacy of a Combination of a Glenohumeral Intra-articular Injection With a Suprascapular Nerve Block Versus a Glenohumeral Intra-articular Corticosteroid Injection in Retractile Capsulitis

Role: lead

NCT05749276Phase 1Recruiting

Escalation of Doses of Daratumumab in Combination With Chemotherapy (Idarubicin and Cytarabine or CPX-351) in Patients of 60 Years Old or More With Adverse Risk Acute Myeloblastic Leukemia (AML) (DARALAM)

Role: lead

NCT06235892Phase 3Recruiting

Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft Failure

Role: lead

NCT04012138Phase 4Completed

Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia

Role: lead